healthcare-thumbnail.png

Adrenocortical Carcinoma (ACC) Market Research Report

Published: 2025 - January

Report Code: VMR-17691

Region: Global

Request Sample
Customization
Ask an Expert
Enquire Enquire Before Buying

Adrenocortical Carcinoma (ACC) Market Analysis

The Adrenocortical Carcinoma (ACC) Market encompasses treatments and therapies for a rare and aggressive malignancy originating in the adrenal cortex. ACC is characterized by excessive hormone production and rapid disease progression, necessitating comprehensive management approaches that include chemotherapy, targeted therapy, immunotherapy, and supportive care. As a highly underserved market, ACC is witnessing increased focus from pharmaceutical companies aiming to address unmet medical needs and improve patient outcomes.

Disruptive Impact and Opportunities:

Emerging therapies like Relacorilant and Ipilimumab are advancing treatment paradigms by targeting novel pathways and immune checkpoints. Advances in combination therapies and precision medicine are streamlining patient management, offering more tailored treatment options. Efforts to minimize treatment-related toxicities through refined drug delivery systems and targeted approaches are gaining traction. The market is expected to grow significantly, driven by expanding clinical trials, increasing awareness, and rising investments in R&D for rare cancers.

Adrenocortical Carcinoma (ACC) Market Segmentation - Emerging Drugs

  • Relacorilant

  • Ipilimumab

Adrenocortical Carcinoma (ACC) Market Segmentation - Marketed Drugs

  • Fosfestrol

  • Mitomycin

  • Mitotane

  • Lysodren

Key Companies:

  • HRA Pharma

  • Takeda Pharmaceuticals

  • Pfizer Inc.

  • Novartis AG

  • Bayer AG

  • Bristol-Myers Squibb Company

  • Ipsen Biopharmaceuticals, Inc.

  • Exelixis, Inc.

  • Genentech, Inc.

  • Merck KGaA

Adrenocortical Carcinoma (ACC) Market Segmentation - By Type

·  Chemotherapy

  • Mitotane-Based Regimens

  • Platinum-Based Chemotherapy

  • Taxanes

  • Antimetabolites

·  Targeted Therapy

  • Tyrosine Kinase Inhibitors (TKIs)

  • Monoclonal Antibodies

·  Immunotherapy

  • Immune Checkpoint Inhibitors

  • Cancer Vaccines

·  Combination Therapy

  • Chemotherapy + Targeted Therapy

  • Chemotherapy + Immunotherapy

·  Hormonal Therapy

  • Glucocorticoid Replacement Therapy

  • Mineralocorticoid Replacement Therapy

·  Others

  • Supportive Care

Adrenocortical Carcinoma (ACC) Market Segmentation -  By Administration Type

  • Oral

  • Intravenous (IV)

  • Intramuscular (IM)

  • Subcutaneous

  • Others

What’s in It for You?

  • Comprehensive insights into the latest emerging and marketed therapies.

  • Strategic analysis of key players driving innovation in the ACC market.

  • Market dynamics and growth opportunities to aid in strategic decision-making.

  • In-depth evaluation of current treatment gaps and areas for investment.

  1. Adrenocortical Carcinoma Market - Executive Summary

    1. Introduction

    2. Objectives

    3. Key Findings

      1. Market Size 2025 & 2030: By Key Country (10MM)

      2. Global Market Size 2025 & 2030:: By Key Segment

      3. Key Investments & Startup Analysis

    4. Research Methodology

  2. Understanding the Disease

    1. Disease Overview

    2. Classification

    3. Signs and Symptoms

    4. Risk Factors

    5. Causes

    6. Disease Biology & Digital Innovations

    7. Stages & Staging System

    8. Diagnostic Algorithm

    9. Current Treatment Practices & Algorithm

    10. Current Standard of Care and Treatment Gaps

    11. Patient Demographics and Treatment Pathways

  3. Guidelines

  4. Unmet Needs

  5. Epidemiology and Patient Population

    1. Epidemiology Key Findings

    2. Assumptions and Rationale: 10MM

    3. Epidemiology Scenario: 10MM

    4. U.S. Epidemiology Scenario

    5. EU-5 Epidemiology

      1. U.K. Epidemiology Scenario

      2. Germany Epidemiology Scenario

      3. France Epidemiology Scenario

      4. Italy Epidemiology Scenario

      5. Spain Epidemiology Scenario

    6. Japan Epidemiology Scenario

    7. China Epidemiology Scenario

    8. Australia Epidemiology Scenario

    9. India Epidemiology Scenario   

  6. Real-world Data & Real-world Evidence

  7. Drug Development Landscape

    1. Existing Key Drug Candidate Profiles/ Marketed Therapies

    2. Competitive Analysis and Differentiation

    3. Overview of Similar/Competing Drugs in Clinical Trials

    4. Future Trends and Emerging Drugs

  8. Regulatory Strategy and Potential Challenges

    1. Regulatory Pathways in Key Markets

    2. Anticipated Regulatory Hurdles and Mitigation Strategies

    3. Case Studies in Oncology Drug Regulation

    4. Impact of Potential Changes to Regulatory Framework

  9. Commercial Landscape

    1. Market Size & Growth Rates

    2. Key Approvals & Anticipated Loss of Exclusivity

    3. PESTLE & Porter’s Five Forces Analysis

    4. Market Shares, Positioning/Ranking

    5. Market Drivers

    6. Identification of Threats

    7. Digital Evolution in Commercialization

  10. Market Segmentation

  11. Pricing, Reimbursement, and Access

    1. Competitive Pricing Analysis

    2. Reimbursement Landscape and Challenges

    3. Strategies for Market Access and Equity

    4. Patient Spending/Expenditure Analysis

  12. Future Trends, Disruptions, and Opportunities

    1. Analysis of Emerging Trends

    2. Technological Impact

    3. Impact of Potential Market Disruptors

    4. Opportunities for Future Development and Expansion

    5. Considerations for Investment Opportunities

  13. Global Market Dynamics

    1. Regional Regulatory Disparities

    2. Cross-Border Partnership Strategies

    3. Global Supply Chain Dynamics

    4. Case Studies: Success and Failure in Global Markets

    5. Strategies for Global Expansion and Localization

  14. Company Profiles

 

 

Download Sample

↻

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Request Sample
Customization
Ask an Expert
Enquire Before Buying
customer-support

Analyst Support

Every order comes with Analyst Support.

report-custom

Customization

We offer customization to cater your needs to fullest.

verify

Verified Analysis

We value integrity, quality and authenticity the most.

© 2025 Virtue Market Research. All Rights Reserved.